RE: More Buys than Sells17 Jan 2020 17:38
Looking ahead five or 10 years, Couldwell expects at least 70% of Tissue Regenix’s business will come from the U.S., for a couple of reasons.
“No. 1 is the availability of and the ability to move porcine tissue around the world, but the most important, the clinical results we’ve got are very attractive and the economics of porcine tissue are very attractive,” he said. “We can bring a superb product with good clinical evidence and good clinical outcomes into a marketplace.”
AND
We continue to look at ways to develop relationships with our strategic partners and have entered investigational discussions for geographic expansion through licensing or distribution agreements with a number of additional potential partners.
ALSO
Proactive interview 2018..."watch this space" regarding ASIA news.
Licencing agreements on their way?